相似文献
1
Radiation dose-volume effects in the lung.
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S70-6. doi: 10.1016/j.ijrobp.2009.06.091.
2
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):172-187. doi: 10.1016/j.ijrobp.2018.11.028. Epub 2018 Nov 26.
3
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):110-5. doi: 10.1016/j.ijrobp.2009.01.036.
4
A novel method to incorporate the spatial location of the lung dose distribution into predictive radiation pneumonitis modeling.
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1549-55. doi: 10.1016/j.ijrobp.2011.05.007. Epub 2011 Jul 6.
5
Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):455-60. doi: 10.1016/0360-3016(95)00009-N.
6
Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):190-5. doi: 10.1016/j.ijrobp.2012.03.041. Epub 2012 Aug 25.
7
Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1124-1132. doi: 10.1016/j.ijrobp.2019.02.039. Epub 2019 Feb 26.
8
Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy.
Radiat Oncol. 2020 Feb 13;15(1):33. doi: 10.1186/s13014-020-1479-6.
9
The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis.
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):125-31. doi: 10.1016/j.ijrobp.2005.09.047. Epub 2006 Jan 19.
10
Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):112-24. doi: 10.1016/j.ijrobp.2005.11.046.
引用本文的文献
1
Induction chemoradiotherapy achieves long-term recurrence-free survival in locally advanced pulmonary lymphoepithelioma-like carcinoma: a case report and literature review.
Front Immunol. 2025 Jul 31;16:1605900. doi: 10.3389/fimmu.2025.1605900. eCollection 2025.
2
The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis.
Transl Lung Cancer Res. 2025 Jun 30;14(6):2074-2088. doi: 10.21037/tlcr-2024-1284. Epub 2025 Jun 26.
3
Combination of radiotherapy and ICIs in advanced hepatocellular carcinoma: A systematic review of current evidence and future prospects (Review).
Oncol Lett. 2025 May 14;30(1):342. doi: 10.3892/ol.2025.15088. eCollection 2025 Jul.
4
Presence of Tissue Expanders Does Not Affect Radiotherapy Dose Distribution to Heart and Lungs.
Plast Reconstr Surg Glob Open. 2025 May 28;13(5):e6819. doi: 10.1097/GOX.0000000000006819. eCollection 2025 May.
5
Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Radiotherapy in Curative Breast Cancer Patients Induced Pneumonitis: A Case Report.
Life (Basel). 2025 Apr 27;15(5):709. doi: 10.3390/life15050709.
6
A Statistical Approach to Assess Biological Equivalent Mean Organ Dose (MOD) for Different Fractionations in Thoracic Radiotherapy.
Biomedicines. 2025 May 2;13(5):1110. doi: 10.3390/biomedicines13051110.
7
Optimal dose-volume histogram thresholds for radiation pneumonitis prevention in lung cancer patients receiving immunotherapy.
Radiat Oncol. 2025 Apr 22;20(1):60. doi: 10.1186/s13014-025-02639-2.
8
Comprehensive clinical evaluation of novel 4DCT-based lung function imaging methods.
J Appl Clin Med Phys. 2025 Jun;26(6):e70088. doi: 10.1002/acm2.70088. Epub 2025 Apr 8.
9
Case Report: Grade 4 pneumonitis occurred after thoracic radiotherapy and dacomitinib in a patient with lung adenocarcinoma.
Front Oncol. 2025 Feb 25;15:1436134. doi: 10.3389/fonc.2025.1436134. eCollection 2025.
10
Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT.
Strahlenther Onkol. 2025 Mar 6. doi: 10.1007/s00066-025-02377-0.
本文引用的文献
1
A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis.
Acta Oncol. 2012 Nov;51(8):975-83. doi: 10.3109/0284186X.2012.718093. Epub 2012 Sep 5.
2
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Radiother Oncol. 2008 Apr;87(1):17-23. doi: 10.1016/j.radonc.2008.02.005. Epub 2008 Mar 17.
3
Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1143-50. doi: 10.1016/j.ijrobp.2007.11.011. Epub 2008 Feb 8.
4
Radiation-induced lung injury. Assessment, management, and prevention.
Oncology (Williston Park). 2008 Jan;22(1):37-47; discussion 52-3.
5
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):985-92. doi: 10.1016/j.ijrobp.2007.04.077. Epub 2007 Aug 6.
6
The North American experience with stereotactic body radiation therapy in non-small cell lung cancer.
J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S101-12. doi: 10.1097/JTO.0b013e318074e4fa.
7
Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors.
Radiat Oncol. 2007 Jun 7;2:21. doi: 10.1186/1748-717X-2-21.
8
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):350-7. doi: 10.1016/j.ijrobp.2007.03.011. Epub 2007 Apr 30.
9
Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):94-102. doi: 10.1016/j.ijrobp.2006.12.031. Epub 2007 Feb 22.
10
Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis.
Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):759-67. doi: 10.1016/j.ijrobp.2006.10.001.
Zotero 插件